Role of Diet and Supplementation with Omega-3 Polyunsaturated Fatty Acids for Managing Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis

1. Association for Motor Disabilities an multiple sclerosis, Bulgarian Association of Neurologists. [National consensus for diagnosing and treatment of multiple sclerosis]. Milonov I, editor, 2021. Bulgarian. Search in Google Scholar

2. Drenska K. [Multiple Sclerosis and Comorbidity – Impact on the Quality of Life] [Dissertation]. Varna: Medical University-Varna; 2016. Bulgarian. Search in Google Scholar

3. Trenova A. [Multiple Sclerosis – Genetic, Immunological and Clinico-neuropsychological Correlations] [Dissertation]. Plovdiv: Medical University-Plovdiv; 2018. Bulgarian. Search in Google Scholar

4. GBD 2016 Motor Neuron Disease Collaborators. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1083-97. Search in Google Scholar

5. Zlatareva E, Milanov I, Ivanova SH, Georgiev DP. Tumor-like lesions in a patient diagnosed with multiple sclerosis as non-onset manifestation of the disease. Mov disor. 2020;17(1):47-52. Search in Google Scholar

6. Azis T, Roy H. Indications and approaches for functional neurosurgery in multiple sclerosis, including the role for lesion surgery and deep brain stimulation. MRA. 2020;8(6):2-14.10.18103/mra.v8i6.2147 Search in Google Scholar

7. Mladenoski M, Vasilev N, Ovcharov M, Valkov I. Basic neuronavigation options for cortical and subcortical brain lesions surgery. J Biomed Clin Res. 2018;11(2):141-9.10.2478/jbcr-2018-0020 Search in Google Scholar

8. Al Ammar W, Albeesh F, Ibrahim L, Algindan Y, Yamani L, Khattab R. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci. 2021;24(7):569-79.10.1080/1028415X.2019.165956031462182 Search in Google Scholar

9. Avallone R, Vitale G, Bertolotti M. Omega-3 fatty acids and neurodegenerative diseases: New evidence in clinical trials. Int J Mol Sci. 2019;20(17), 4256.10.3390/ijms20174256 Search in Google Scholar

10. Black LJ, Baker K, Ponsonby AL, van der Mei I, Lucas RM, Pereira G. A Higher Mediterranean diet score, including unprocessed red meat, is associated with reduced risk of Central Nervous System demyelination in a case-control Study of Australian adults. J Nutr. 2019;149(8):1385-92.10.1093/jn/nxz08931131415 Search in Google Scholar

11. Bromley L, Horvath PJ, Bennett SE, Weinstock-Guttman B, Ray AD. Impact of nutritional intake on function in people with mild-to-moderate multiple sclerosis. Int J MS Care. 2019;21(1)1-9.10.7224/1537-2073.2017-039639082030833865 Search in Google Scholar

12. MS-UK [Internet]. Diet and supplements. Choices booklet. 2019. Available from: https://ms-uk.org/choices-diet-and-supplements-content/ Search in Google Scholar

13. Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord. 2019;36:101393.10.1016/j.msard.2019.10139331574403 Search in Google Scholar

14. Fitzgerald KC, Sand IK, Senders A, Spain R, Giesser B, et al. Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward. Mult Scler Relat Disord. 2019;37:101478.10.1016/j.msard.2019.10147831704546 Search in Google Scholar

15. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, et al. International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of Major Depressive Disorder. Psychother Psychosom. 2019;88(5):263-73.10.1159/00050265231480057 Search in Google Scholar

16. Ruiz1 F, Vigne1 S, Pot C. Resolution of inflammation during multiple sclerosis. Semin Immunopathol. 2019;41(6):711-726.10.1007/s00281-019-00765-0688124931732775 Search in Google Scholar

17. Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017;18(1):19.10.1186/s12868-016-0312-5525986328114887 Search in Google Scholar

18. Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord. 2016;9:80-90.10.1016/j.msard.2016.07.00127645350 Search in Google Scholar

19. Parikh R, Bates JH, Poynter ME, Suratt BT, Parsons PE, Kein SL, et al. Pharmacokinetics of omega-3 fatty acids in patients with severe sepsis compared with healthy volunteers: A prospective cohort study. Clin Nutr. 2020;39(3):958-65.10.1016/j.clnu.2019.03.040678538331005335 Search in Google Scholar

20. Kouchaki E, Afarini M, Abolhassani J, Mirhosseini N, Bahmani F, Masoud SL, et al. High-dose ω-3 fatty acid plus vitamin D3 supplementation affects clinical symptoms and metabolic status of patients with multiple sclerosis: A randomized controlled clinical trial. J Nutr. 2018;148(8):1380-6.10.1093/jn/nxy11629982544 Search in Google Scholar

21. Labuschagne IL, Blaauw R. An anti-inflammatory approach to the dietary management of multiple sclerosis: a condensed review. South Afr J Clin Nutr. 2018;31(3):67-73.10.1080/16070658.2018.1465652 Search in Google Scholar

22. Langer-Gould A, Black LJ, Waubant E, Smith JB, Wu J. Seafood fatty acid biosynthesis genes, and multiple sclerosis susceptibility. Mult Scler J. 2020;26(12):1476-85.10.1177/1352458519872652757320033063621 Search in Google Scholar

23. Li X, Bi X, Wang S, Zhang Z, Li F, Zhao AZ. Therapeutic potential of ω-3 polyunsaturated fatty acids in human autoimmune diseases. Front Immunol. 2019;10:2241.10.3389/fimmu.2019.02241677688131611873 Search in Google Scholar

24. Capone F, Collorone S, Cortese R, Di Lazzaro V, Moccia M. Fatigue in multiple sclerosis: The role of thalamus. Mult Scler. 2020;26(1):6-16.10.1177/135245851985124731138052 Search in Google Scholar

25. Cipollini V, Anrather J, Orzi F, Iadecola C. Th17 and cognitive impairment: possible mechanisms of action. Front Neuroanat. 2019;13:95.10.3389/fnana.2019.00095687748131803028 Search in Google Scholar

26. De Souza Moreira BB, de Almeida Franzoi AE, Gonзalves MVM, do Nascimento OJM, Becker J, Peron JPS. Lymphocytes T Helper 17 in multiple sclerosis: regulation by intestinal microbiota. J Neurol Exp Neurosci. 2019;5(1): 40-7.10.17756/jnen.2019-051 Search in Google Scholar

27. Drenska K, Drenski T, Kaprelyan A. Feeling of happiness in patients with multiple sclerosis and comorbidity. J of IMA. 2019;25(1):2390-5.10.5272/jimab.2019251.2390 Search in Google Scholar

28. Gutierrez S, Svahn SL, Johansson ME. Effects of Omega-3 fatty acids on immune cells. Int J Mol Sci. 2019;20(20), 5028.10.3390/ijms20205028 Search in Google Scholar

29. Mousavi Nasl-Khameneh A, Mirshafiey A, Naser Moghadasi A, Chahardoli R, Mahmoudi M, Parastouei K, et al. Combination treatment of docosahexaenoic acid (DHA) and all-transretinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis. Neurol Res. 2018;40(1):11-17.10.1080/01616412.2017.138280029155646 Search in Google Scholar

30. Maxwell K, Wahls T, Browne RW, Rubenstein L, Bisht B, Chenard C, et al. Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. PLoS One. 2019;14(6):e0218075.10.1371/journal.pone.0218075658125631211794 Search in Google Scholar

31. Penesova A, Dean Z, Kollar B, Havranova A, Imrich R, Vlček M, et al. Nutritional intervention as an essential part of multiple sclerosis treatment? Physiol Res. 2018;67(4):521-33.10.33549/physiolres.93369429750884 Search in Google Scholar

32. Pommerich UM, Brincks J, Christensen ME. Is there an effect of dietary intake on MS-related fatigue? A systematic literature review. Mult Scler Relat Disord. 2018;25:282-91.10.1016/j.msard.2018.08.01730170268 Search in Google Scholar

33. Reimers A, Ljung H. The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders. Ther Adv Psychopharmacol. 2019;9:1-18.10.1177/2045125319858901659166431258889 Search in Google Scholar

34. Tryfonos C, Mantzorou M, Fotiou D, Vrizas M, Vadikolias K, Pavlidou E, et al. Dietary supplements on controlling multiple sclerosis symptoms and relapses: current clinical evidence and future perspectives. Medicines (Basel). 2019;6(3):95.10.3390/medicines6030095678961731547410 Search in Google Scholar

35. Drenska K, Drenski T, Kaprelyan A, Dimitrov I. [Fatigue in patients with multiple sclerosis with and without concomitant diseases]. Neurology and psychiatry. 2017;XLVIII(3):26-8. Bulgarian Search in Google Scholar

36. Sepidarkish M, Akbari-Fakhrabadi M, Daneshzad E, Yavari M, Rezaeinejad M, Morvaridzadeh M, et al. Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on oxidative stress parameters: A systematic review and meta-analysis. Clin Nutr. 2020;39(4):1019-25.10.1016/j.clnu.2019.05.00431128941 Search in Google Scholar

37. Shinto L, Marracci G, Mohr DC, Bumgarner L, Murchison C, Senders A, et al. Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study. PLoS One. 2016;11(1):e0147195.10.1371/journal.pone.0147195472331626799942 Search in Google Scholar

38. Shrestha P, Zhou XR, Pillai SV, Petrie J, de Feyter R, Singh S. Comparison of the substrate preferences of ω-3 fatty acid desaturases for long chain polyunsaturated fatty acids. Int J Mol Sci. 2019;20(12):3058.10.3390/ijms20123058662740831234541 Search in Google Scholar

39. Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve K, Hovdal H, et al. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012;69(8):1044-51.10.1001/archneurol.2012.28322507886 Search in Google Scholar

40. Van AL, Hachem M, Lagarde M, Bernoud-Hubac N. Omega-3 Docosahexaenoic Acid is a mediator of fate-decision of adult neural stem cells. Int J Mol Sci. 2019;20(17),4240.10.3390/ijms20174240 Search in Google Scholar

41. Hass U, Herpich C, Norman K. Anti-inflammatory diets and fatigue. Nutrients. 2019;11(10):2315.10.3390/nu11102315683555631574939 Search in Google Scholar

42. Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019;31(9):559-67.10.1093/intimm/dxz00130772915 Search in Google Scholar

43. Katz-Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7(3):150-60.10.1007/s13668-018-0236-z613238230117071 Search in Google Scholar

44. Katz-Sanda I, Bennb E, Fabiana M, Fitzgeraldc K, Digga E, Deshpande R, et al. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2019;36:101403.10.1016/j.msard.2019.10140331610401 Search in Google Scholar

45. Sayon-Orea C, Razquin C, Bullo M, Corella D1, Fito M, Romaguera D, et al. Effect of a nutritional and behavioral intervention on energy-reduced Mediterranean diet adherence among patients with metabolic syndrome: Interim analysis of the PREDIMED-Plus randomized clinical trial. JAMA. 2019;322(15):1486-99.10.1001/jama.2019.14630680227131613346 Search in Google Scholar

46. Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):397-404.10.1016/j.plefa.2005.05.02416099630 Search in Google Scholar

47. Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M. A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis. Nutrients. 2019;11(7):1528.10.3390/nu11071528668297231284389 Search in Google Scholar

48. Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind M, Sacco R, et al. Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol. 2012;69(2):251-6.10.1001/archneurol.2011.548328155022332193 Search in Google Scholar

49. Mische LJ, Mowry E. The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: a review. Curr Treat Options Neurol. 2018;20(4):8.10.1007/s11940-018-0494-529549521 Search in Google Scholar